AACR 2010 Annual Meeting Press Conferences - # - American Association for Cancer Research Photos

gallery pages: 1 2 3 4 5 6 > >>

< 1 of 63 >

Washington, D.C. - AACR 101st Annual Meeting 2010: David M. Reese, M.D., discusses Abstract LB-174: Use of massively parallel, next-generation sequencing to identify gene mutations beyond KRAS that predict response to panitumumab in a randomized, Phase III, monotherapy study of metastatic colorectal cancer (mCRC) during the Emerging Technologies and Therapies Press Conference at the American Association for Cancer Research Annual meeting here today, here today, Sunday, April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday, April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Jennifer Sims-Mourtada, Ph.D., Emerging Technologies and Therapies Press Conference

Washington, D.C. - AACR 101st Annual Meeting 2010: Jennifer Sims-Mourtada, Ph.D., discusses Abstract 4335: Imaging of cancer stem cells with radiolabeled Hedgehog during the Emerging Technologies and Therapies Press Conference at the American Association for Cancer Research Annual meeting here today, Sunday, April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday, April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Jennifer Sims-Mourtada, Ph.D., Emerging Technologies and Therapies Press Conference

Washington, D.C. - AACR 101st Annual Meeting 2010: Michael G. Agadjanyan, Ph.D., D.Sc., discusses Abstract LB-319: A novel cancer-testis antigen, BORIS-based vaccine delivered by dendritic cells is effective against metastatic disease during the Emerging Technologies and Therapies Press Conference at the American Association for Cancer Research Annual meeting here today,here today, Sunday, April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday, April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Jennifer Sims-Mourtada, Ph.D., Emerging Technologies and Therapies Press Conference

Washington, D.C. - AACR 101st Annual Meeting 2010: Erwin Lobo, lung cancer survivor,discusses Abstract LB-1: The BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination): Personalizing therapy for lung cancer during the The BATTLE Trial Press Conference at the American Association for Cancer Research Annual meeting here today, Sunday April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Erwin Lobo, Battle Trial

Washington, D.C. - AACR 101st Annual Meeting 2010: Deepa Subramaniam, MD, discusses Abstract LB-1: The BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination): Personalizing therapy for lung cancer during the The BATTLE Trial Press Conference at the American Association for Cancer Research Annual meeting here today, Sunday April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Deepa Subramaniam, Battle Trial

Washington, D.C. - AACR 101st Annual Meeting 2010: Jeffrey Wigbels, lung cancer survivor,discusses Abstract LB-1: The BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination): Personalizing therapy for lung cancer during the The BATTLE Trial Press Conference at the American Association for Cancer Research Annual meeting here today, Sunday April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Jeffrey Wigbels, Battle Trial

Washington, D.C. - AACR 101st Annual Meeting 2010: Edward S. Kim, M.D.,discusses Abstract LB-1: The BATTLE trial (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination): Personalizing therapy for lung cancer during the The BATTLE Trial Press Conference at the American Association for Cancer Research Annual Meeting here today, Sunday April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Edward S. Kim, M.D., Battle Trial

Washington, D.C. - AACR 101st Annual Meeting 2010: Sunitha Nagrath, Ph.D., discusses Abstract 1136: Detection and characterization of circulating tumor cells in localized and metastatic prostate cancer patients using CTC-Chip microfluidic technology during the Emerging Technologies and Therapies Press Conference at the American Association for Cancer Research Annual meeting here today, Sunday April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Sunitha Nagrath, Ph.D., Emerging Technologies and Therapies Press Conference

Washington, D.C. - AACR 101st Annual Meeting 2010: David M. Reese, M.D., discusses Abstract LB-174: Use of massively parallel, next-generation sequencing to identify gene mutations beyond KRAS that predict response to panitumumab in a randomized, Phase III, monotherapy study of metastatic colorectal cancer (mCRC) during the Emerging Technologies and Therapies Press Conference at the American Association for Cancer Research Annual meeting here today, here today, Sunday, April 18, 2010. More than 17,000 physicians, researchers, healthcare professionals, cancer survivors and patient advocates from 60 countries are attending the meeting which is being held at the Walter E Washington Convention Center. The meeting covers the breadth of cancer science from basic through clinical and epidemiological research. Date: Sunday, April 18, 2010 Photo by © AACR/Todd Buchanan 2010 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154. Keywords: Jennifer Sims-Mourtada, Ph.D., Emerging Technologies and Therapies Press Conference

filename: 10AACRtb_3074 |

Share photo: links, forums, blogs |

gallery pages: 1 2 3 4 5 6 > >>

< 1 of 63 >